University of Kansas Medical Center

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

172

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

9 drugs in development

Phase 32

Phase 23

Phase 15

Preclinical6

By Therapeutic Area

top 6

Oncology

424%

Metabolic & Endocrine

212%

Cardiovascular

212%

Infectious Disease

16%

Immunology

16%

Psychiatry

16%

R&D Momentum

76/100

Pipeline Velocity

41/100

Trial Completion Rate

68/100

Pipeline Concentration

22/100

Pipeline Freshness

60/100

Strategic Signals

↗Active in Metabolic & Endocrine but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 18, 2026

Active, not recruiting

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Sep 9, 2026

Completed

Therapeutic Diets in Alzheimer's Disease

Earlier

Aug 28, 2026TrialNutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children

Aug 28, 2026TrialThe Use of Topical Tranexamic Acid Versus Thrombin Spray for the Management of Split Thickness Skin Graft Recipient Site in Burn Management

Aug 21, 2026TrialImproving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction (PASSION Study)

Aug 20, 2026TrialFeasibility, Acceptability, and Preliminary Treatment Efficacy of Early Cognitive Behavioral Therapy for Insomnia (CBT-I) to Mitigate Insomnia Symptoms and Fatigue and Improve Health-related Quality of Life in Individuals Planning to Undergo Hematopoietic Stem Cell Transplant (HSCT)

Aug 19, 2026TrialPROspective Evaluation of GErmline Mutations, Cancer Outcome and Tissue Biomarkers: A Registry for Patients With Triple Negative Breast Cancer and Germline Mutations

Aug 15, 2026TrialImproving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income Black Women in Kansas

4 more events

Aug 14, 2026TrialA Single-center, Prospective, Double-blind, Randomized Controlled Trial Evaluating Iovera° Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Facet-mediated Chronic Low Back Pain

Aug 14, 2026TrialIntensive Longitudinal Assessment of Stress and Stress-related Concepts Across a Behavioral Weight Loss Intervention: INSTANT Study

Aug 13, 2026TrialTesting Effects of Swim Instruction on Autistic Children's Swimming and Water Safety Skills

Aug 13, 2026TrialEnacting Active Survivorship: Implementation of Weight Management Strategies in Endometrial Cancer Survivors

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

QS-21Phase 2

TG01 VaccinePhase 2

Relapsed or Refractory B-Cell Malignancies

DuoCAR20.19.22-D95Phase 1

Unknown / Other

Chronic Pain

Clonidine PillPreclinical

Clonidine

Clonidine PillPhase 3

Estrogen

BazedoxifenePhase 2

Pulmonary Disease

Hyperpolarized Xe129Phase 1

Smokers

ChantixPhase 3

Tobacco Use Disorder

ChantixPhase 1

Showing 15 of 20 programs

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)